CD103 Deficiency Prevents Graft-Versus-Host Disease but Spares Graft-Versus-Tumor Effects Mediated by Alloreactive CD8 T Cells

PLoS ONE - United States
doi 10.1371/journal.pone.0021968
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Graft-Versus-Host Disease

New England Journal of Medicine
Medicine
1991English

Graft Versus Host Disease

Bone Marrow Transplantation
TransplantationHematology
2000English

Graft Versus Host Disease

2020English

Both Perforin and Fas Ligand Are Required for the Regulation of Alloreactive CD8+ T Cells During Acute Graft-Versus-Host Disease

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Intestinal Graft Versus Host Disease.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1991English

018 Langerhans Cells Suppress CD8 T Cells in Situ During Acute Graft-Versus-Host Disease-Like Autoimmune Mucocutaneous Disease

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Depletion of Naïve Lymphocytes With Fas Ligand Ex Vivo Prevents Graft-Versus-Host Disease Without Impairing T Cell Support of Engraftment or Graft-Versus-Tumor Activity

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Donor CD8+ T Cells Mediate Graft-Versus-Leukemia Activity Without Clinical Signs of Graft-Versus-Host Disease in Recipients Conditioned With Anti-Cd3 Monoclonal Antibody

Journal of Immunology
AllergyImmunology
2007English

CD38 Bright Effector Memory CD8+ T Cell Populations Predict Acute Graft Versus Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy